About Human Regenerative Technologies
Human Regenerative Technologies is a Healthcare company based in El Segundo (United States) founded in 2016. It provides advanced tissue allografts for medical applications and wound care. It operates on a B2B model. Human Regenerative Technologies offers products and services including HydraTek Process and Amniotic Allografts. Its focus areas include Biotech, Regenerative Medicine, Tissue Allografts and Medical Devices. Its legal entity is Human Regenerative Technologies, LLC. Its competitors include BioLife Solutions, RoosterBio and ArunA Bio; 2 of its 3 listed competitors have raised funding.
Company details
Human Regenerative Technologies focuses on developing and preserving amniotic and placental tissues through innovative processes like HydraTek. They operate as a tissue bank, sourcing from U.S. donors via C-section deliveries, and supply products for wound care and regenerative medicine. Based in El Segundo, California, they emphasize safety standards and partner with facilities for distribution, ensuring non-immunogenic allografts for medical procedures.
- Headquarters El Segundo, United States
- SectorsHealthcare
- Email••••••••
- Website humantissue.com
- Legal Name Human Regenerative Technologies, Llc
Products & Services of Human Regenerative Technologies
Human Regenerative Technologies offers a comprehensive portfolio of products and services, including HydraTek Process and Amniotic Allografts.
Revolutionary method for preserving amniotic and placental allografts.
Derived tissues for wound care and regenerative applications.
Competitors of Human Regenerative Technologies
Human Regenerative Technologies has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and ArunA Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| arunabio.com | 2017 | Athens, United States | $38.51M | Neural exosome platform is developed for neurodegenerative disease therapeutics. |
Detailed competitors of Human Regenerative Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Human Regenerative Technologies (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Human Regenerative Technologies
Human Regenerative Technologies was founded in 2016.
Human Regenerative Technologies is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
Human Regenerative Technologies focuses on developing and preserving amniotic and placental tissues through innovative processes like HydraTek. They operate as a tissue bank, sourcing from U.S. donors via C-section deliveries, and supply products for wound care and regenerative medicine. Based in El Segundo, California, they emphasize safety standards and partner with facilities for distribution, ensuring non-immunogenic allografts for medical procedures.
Human Regenerative Technologies's top competitors include RoosterBio, BioLife Solutions and ArunA Bio.
Human Regenerative Technologies offers HydraTek Process and Amniotic Allografts.
Human Regenerative Technologies operates through Human Regenerative Technologies, Llc.